@article{2d5462d295184076a2289ad60f52d1e2,
title = "Association of weight loss maintenance and weight regain on 4-year changes in CVD risk factors: The action for health in diabetes (Look AHEAD) clinical trial",
abstract = "OBJECTIVE: Short-term weight loss improves cardiovascular disease (CVD) risk factors. We sought to determine the longer-term effects of maintaining weight loss or, conversely, regaining weight. RESEARCH DESIGN AND METHODS: We used data from Action for Health in Diabetes (Look AHEAD), a randomized trial of intensive lifestyle intervention (ILI) compared to a control condition in over weight/obese individuals with type 2 diabetes. ILI participants were grouped according to weight change patterns, as follows: 1) no weight loss (±3% at years 1 and 4); 2) moderate weight loss (3-8% at years 1 and 4); 3) large weight loss (8-20% at years 1 and 4); 4) moderate loss/full regain (3-8%atyear 1/±3%atyear 4);5) large loss/full regain (8-20% at year 1/± 3% year 4); and 6) large loss/partial regain (8-20% at year 1/3-8% at year 4) and changes in CVD risk factors were compared. RESULTS: Adjusting for baseline differences and medication use, larger weight losses produced greater improvements in HbA1c, systolic blood pressure, HDL cholesterol, and triglycerides at years 1 and 4 (all P ≤ 0.02). Despite maintenance of weight loss, HbA1c levels worsened between years 1 and 4, and remained below baseline only in those with large weight losses. We found no negative associations of losing and regaining weight relative to not having lost weight. Moreover, those who had large initial weight loss but full regain of weight had greater improvements in HbA1c levels at year 4 than those with smaller or no initial weight loss. CONCLUSIONS: Larger initial weight loss should be encouraged in individuals with type 2 diabetes, despite the possibility of regain.",
author = "{Action for Health in Diabetes (Look AHEAD) Study Group} and Wing, {Rena R.} and Espeland, {Mark A.} and Clark, {Jeanne M.} and Hazuda, {Helen P.} and Knowler, {William C.} and Pownall, {Henry J.} and Jessica Unick and Thomas Wadden and Lynne Wagenknecht",
note = "Funding Information: This study is supported by the Department of Health and Human Services through the following cooperative agreements with the National Institutes of Health: DK-57136, DK-57149, DK-56990, DK-57177, DK-57171, DK-57151, DK-57182, DK-57131, DK-57002, DK-57078, DK-57154, DK-57178, DK-57219, DK-57008, DK-57135,and DK-56992. The following federal agencies have contributed support: National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute of Nursing Research; National Center on Minority Health and Health Disparities; Office of Research on Women's Health; the Centers for Disease Control and Prevention; and the Department of Veterans Affairs. This research was supported in part by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. The Indian Health Service provided personnel, medical oversight, and use of facilities. Additional support was received from The Johns Hopkins Medical Institutions Bayview General Clinical Research Center (grant M01-RR-02719), the Massachusetts General Hospital Mallinckrodt General Clinical Research Center and the Massachusetts Institute of Technology General Clinical Research Center (grant M01-RR-01066), the University of Colorado Health Sciences Center General Clinical Research Center (grant M01-RR-00051) and Clinical Nutrition Research Unit (P30-DK-48520), the University of Tennessee at Memphis General Clinical Research Center (M01-RR-0021140), the University of Pittsburgh General Clinical Research Center (M01-RR-000056), the Clinical Translational Research Center funded by a Clinical and Translational Science Award (UL1 RR 024153), a National Institutes of Health grant (DK-046204), and a Frederic C. Bartter General Clinical Research Center grant (M01-RR-01346). The following organizations have committed to make major contributions to the Look AHEAD Study: FedEx Corporation; Health Management Resources; LifeScan, Inc., a Johnson & Johnson Company; OPTIFAST of Nestle HealthCare Nutrition, Inc.; Hoffmann-La Roche Inc.; Abbott Nutrition; and Slim-Fast Brand of Unilever North America. Some of the information contained here in was derived from data provided by the Bureau of Vital Statistics, New York City Department of Health and Mental Hygiene. Publisher Copyright: {\textcopyright} 2016 by the American Diabetes Association.",
year = "2016",
month = aug,
day = "1",
doi = "10.2337/dc16-0509",
language = "English (US)",
volume = "39",
pages = "1345--1355",
journal = "Diabetes care",
issn = "0149-5992",
publisher = "American Diabetes Association Inc.",
number = "8",
}